Abstract
Caprine respiratory mycoplasmosis is a major problem in India. Various mycoplasma species cause pneumonia and respiratory problems, thus inflicting huge economic losses in the small ruminant production sector. Though multiple species cause respiratory mycoplasmosis, data regarding species prevalence is deficient in India. The present study was conducted to study the prevalence of respiratory mycoplasmosis caused by Mycoplasma ovipneumoniae in goats using polymerase chain reaction (PCR). A total of 98 nasal swabs were collected, out of which 44 samples were positive for M. ovipneumoniae. A total of 26 animals with explicit clinical signs were selected for comparing the therapeutic efficacy of marbofloxacin and tylosin and were randomly divided into two groups consisting of 13 animals each. Group 1 was treated with marbofloxacin @ 2mg/kg body weight, intramuscularly for 5 days. Group 2 was treated with tylosin @ 10mg/kg body weight, intramuscularly for 5 days. Complete bacteriological recovery rate in group 1 and group 2 was observed as 69.2 per cent and 84.6 per cent respectively by day 11 of treatment. Statistical analysis revealed that marbofloxacin was as effective as tylosin against respiratory mycoplasmosis in goats.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
